ABSTRACT. After experimentally inducing growth retardation by unilateral uterine artery ligation in midpregnancy, placental blood flow (PBF) (microsphere technique) and placental transfer of '4C-aminoisobutyric acid (AIB) and "-methylglucose (MG) were studied at d 44, 50, or 63 of gestation in 19 chronically catheterized awake guinea pigs. At d 44, fetal wt (FW) and placental wt were reduced by 16 and 18%, respectively, in the ligated horn and FW/ PBF was increased by 122%. Placental efficiency to transfer MG and AIB (fetal dpm/g placenta) was maintained in the ligated horn, feto-placental extraction (feto-placental dpm/PBF) was increased, and placental transfer of the substrate analogs (fetal dpm/g fetus) was unchanged. At d 50 and 63, placental wt and FW were reduced in proportion (-40%) in the growth-retarded group and FW/PBF was increased by 80 and 51%, respectively. Placental transfer of AIB was reduced by 33% at d 50 and by 18% at d 63. In addition, placental efficiency to transfer AIB was reduced by 36% at d 50 and by 22% at d 63 in the growthretarded group. Fetal uptake of MG per g fetus was slightly reduced (-6%) at d 50 of gestation, but unaffected at d 63. Extraction of MG from the maternal PBF was increased, whereas the wt-specific transfer capacity of the placenta was unaltered. Our results demonstrate that experimental growth retardation in the guinea pig is associated with a substantial reduction of FW-specific placental transfer of AIB, indicating that the growth-retarded fetus has an impaired supply of amino acids during intrauterine life. This reduction is suggested to be due to alterations at the placental barrier level and will contribute to the development of intrauterine growth retardation independently of the PBF decrease per se. Placental transfer of MG per g fetus was only moderately reduced at d 50 of gestation, but otherwise maintained. Consequently, compromised placental glucose transfer is not likely to be the main cause of fetal hypoglycemia in guinea pig intrauterine growth retardation. (Pediatr Res 28: 203-208, 1990) Abbreviations AIB, '4C-aminoisobutyric acid MG, 3H-methylglucose FW, fetal weight PBF, placental blood flow (mL/min)
IUGR, intrauterine growth retardation PE, polyethylene
Reduced placental transfer of nutrients due to impaired maternal PBF and/or placental dysfunction is implicated as one of the causative factors of IUGR. Varying degrees of fetal hypoglycemia are consistently found in most experimental models of IUGR, such as the fetal sheep (1) and guinea pig (2) , and have also been demonstrated in the undisturbed human fetus (3) . The umbilical vein-artery concentration difference of a-amino nitrogen, measured by cord blood sampling after delivery, is reduced in small-for-gestational-age infants (4), a finding that has been confirmed recently by transabdominal cord sampling (5) .
Reductions in umbilical plasma concentrations of glucose and amino acids do not, however, provide direct evidence for impaired placental transport of these substrates, inasmuch as other factors besides materno-fetal transfer, such as fetal consumption, may influence fetal plasma levels. An approach to circumvent this problem is to measure placental and umbilical blood flows, as well as extraction, which has been done in the experimentally growth-retarded fetal lamb (I). A method that focuses more directly on placental transfer is the use of radioactively labeled substrate analogs. When placental transfer of glucose was investigated with such techniques in the fetal sheep (6) , data suggested that it was enhanced in IUGR. On the other hand, in the anesthetized rat with growth retardation induced by uterine artery ligation, a reduced transfer of both methylglucose and aminoisobutyric acid was demonstrated (7) .
Substrate transfer capacity of the growth-retarded hemochorial placenta has only been investigated in anesthetized and acutely instrumented animals (7, 8) . Anesthesia is known to markedly reduce PBF and may also, together with the acute surgical stress, influence placental transport characteristics. Therefore, the main objective of our investigation was to study placental transfer of AIB and MG in the unstressed guinea pig after experimental induction of fetal growth retardation by unilateral uterine artery ligation in midpregnancy. It is reasonable to assume that if changes in placental substrate transfer have a major impact on fetal growth, they should not only be demonstrable near term, but also during a substantial part of the gestation. For this reason, and to describe possible changes in placental transfer capacity or compensation mechanisms during the development of growth retardation, experiments were performed at three stages of gestation.
MATERIALS AND METHODS
The investigations described in this paper have been approved by . . the local ethical committee for animal experimentation (561 ~a h l~r i n ' s Hospital Foundation.
89).
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Nineteen nulliparous albino guinea pig does of the DunkinHartley strain were used. The animals were allowed free access to food [standard pellets (Ewos, Sodertalje, Sweden) and hay] and water (with ascorbic acid, vitamin E, and selenium added). The animals were maintained in an environment of controlled humidity (40 to 70%) and temperature (18 to 20°C) with a 12-h light-darkness cycle. The day of mating (d 0) was determined by daily inspection of the vaginal membrane. Initially, two females and one male guinea pig were housed together, but after pregnancy was confirmed by palpation of the fetuses at d 15 to 20 of gestation, the does were transferred to a special room in the animal stables and kept alone in separate cages. From d 20 until the day of experimentation, animals were fed 0.2 to 0.3 mL of water daily from a syringe to accustom them to handling.
At 31 to 38 (mean 34.8 + 0.4) d gestation, the animals were anesthetized with 3-4% enflurane together with nitrous oxide/ oxygen (1: 1). Under aseptic conditions and temperature control (rectal temperature 37.5-38S0C), a 2-to 3-cm lower abdominal midline incision was made. The mesometrial fat pad of one of the uterine horns was exposed and the uterine artery ligated. The operation lasted 10-15 min, and the animals were standing up in their cages within 10 min.
At 38 to 40, 42 to 45, or 49 to 53 d gestation, animals were anesthetized with ketamine hydrochloride (30 mg s.c.) and xylazine (3 mg intramuscularly), preceded by atropine (0.05 mg s.c.). Polyethylene catheters (Becton Dickinson & Co., Parsippany, NJ) were inserted into the femoral artery and advanced to the aortic bifurcation (PE 25, inner diameter 0.40 mm, connected to PE 90, inner diameter 0.86 mm), into the left ventricle by cannulation of the right common carotid artery in the retrograde direction (PE 50, inner diameter 0.58 connected to PE 90), and into the right external jugular vein (PE 50 connected to PE 90). The catheters were tunneled s.c. and exteriorized between the scapulae. A small amount of antibiotic paste (Socatyl vet, CibaGeigy, Basel, Switzerland) was applied to the wounds before closure. The operation lasted 30-60 min. During the operation and postoperatively, the animals were given a total volume of 30 mL of physiologic saline i.v. over 2' /2 h. Isoprenaline was added to the fluid at an infusion rate of 1.5 pg/kg x min to preserve cardiac output during anesthesia. Glucose was given (10 mg/kg x min) in the last 20 mL. Catheters were filled with heparinized saline solution and sealed. The animals recovered within 3-5 h after the operation. To maintain patency, the catheters were flushed with heparinized saline every 24 h.
At 44 to 45, 50, or 63 to 64 d gestation, experiments were performed in the animal room with the animal freely moving in its own cage without any visual contact with the experimenter. After connecting the animal to a swivel, it was allowed 1-2 h to accommodate to the experimental situation. Throughout the experiment, arterial blood pressure and heart rate were measured by means of a pressure transducer (P23 ID Statham Gould, Hato Rey, Puerto Rico) and an oscillation detector, respectively. All recordings were made on a Grass Instrument (Quincy, MA) polygraph no. Germany) were used. The microspheres were suspended in saline solution with Tween 80 added. After vigorous vibration with a whirl mixer, 0.6-0.7 mL (corresponding to 400 000-600 000 spheres) were injected into the left ventricle catheter over 45 s, followed by flushing of the catheter with 1 mL of saline solution over 45 s. A reference blood sample was drawn from the abdominal aorta at a rate of 0.65 mL/min from 10 s before the start of the microsphere injection until 75 s after the end of flushing.
At 25 min into the experimental period, 1 mL of blood was sampled from the femoral catheter and the animal was killed by an overdose of barbiturate. After laparotomy, fetuses were promptly dissected out and decapitated to obtain blood samples. Catheter positions were checked and all were found to be adequate. After weighing, placentas and kidneys were partitioned and placed into counting vials. The radioactivity of the samples was determined in a multichannel pulse height analyzer (Packard 5019 connected to Packard 3220; Packard Instrument Co., Inc., Downers Grove, IL). Organ blood flows were calculated by the following formula: Organ blood flow (mL/min) = (No. of microspheres in organ + no. of microspheres in reference blood sample) x withdrawal rate (mL/min). No experiment contained less than 580 microspheres in placentas, kidneys, or reference blood sample. The lower blood flow (mL/min x g) of the two kidneys was divided by the higher blood flow value, giving a ratio 51.0 for each microsphere injection; the mean ratio was 0.95 k 0.01 (range 0.82 to 0.99), indicating an adequate mixing of spheres.
To determine concentrations of substrate analogs, fetuses, placentas (obtained from the gamma radiation counting vials), and blood samples were homogenized in four volumes of distilled water and 20% trichloroacetic acid was added to the homogenates (1 :3). The samples were centrifuged for 10 min at 12 000 x g, supernatants retained, the pellets redissolved in 5-10 mL 5 % trichloroacetic acid, and recentrifuged ( 10 min, 12 000 x g). The supernatants from these two steps were counted separately in a liquid scintillation spectrometer (Packard Tricarb model 3320) after addition of 10 mL of Aquasol-2 (New England Nuclear, Boston, MA) to 1 mL of supernatant. The counting eficiency in the 3H and I4C channels was determined with standard quenching curves. In two experiments, the final pellets were rehomogenized and, after addition of trichloroacetic acid, centrifuged for a third time; this supernatant contained less than 3% of the counts from the first supernatant. AIB-standard (3.68 x lo-'' mol) and MG-standard (2.6 x lO-I3 mol) corresponded to 5 1 000 + 1300 dpm and 30 000 + 200 dpm, respectively, (n = 7).
In total, 135 animals with fetuses in both uterine horns went through the ligation operation. In 26% of these does, fetuses in the ligated horn were dead at the time of catheterization. In another 21 % of the animals, fetuses on the operated side died between catheterization and the day of experimentation. In 10% of the ligated animals, no growth retardation was observed at autopsy. In the rest of the cases (43%), varying degrees of wt 1 reduction were found. However, in a majority of these animals (29% of the initial 139, complications like postoperative deaths of the doe, catheter failure, stressful behavior in the experimental situation, etc., appeared. The rest of the animals (14%) went through successful experiments.
Results are expressed as means + SEM. To evaluate statistical significance of differences between growth-retarded and control groups, t test for paired observations was used.
RESULTS
General characteristics of the 19 animals are given in Table 1 . In the d 50 and d 63 groups, growth retardation was arbitrarily defined as >20% wt reduction compared with the mean FW in the control horn. In cases of more than one control or growthretarded fetus present in the horn, a mean value was calculated for the horn. In one experiment, at d 63, the nonligated horn contained two small fetuses together with one normal-sized control; these two runts exhibited the same changes in substrate transfer parameters as the small fetuses in the ligated horn and were included in the growth-retarded group. At d 44, data from all fetuses in the ligated horn are presented, because at this gestational age no substantial reduction of FW was recorded. At d 44, FW was reduced by 16% and placental wt by 18% in the ligated horn ( Table 2 ). The moderate effect of uterine artery ligation on fetal growth was not due to an unsuccessful reduction of PBF, inasmuch as FW/PBF was increased by 112%. At d 50 and 63 of gestation, FW/PBF was increased by 80 and 51%, respectively, whereas fetal and placental wt were reduced in proportion (-40%) in the growth-retarded group.
The uptakes of AIB and MG in placentas and fetuses are presented as dpm in Table 3 . Feto-placental dpm/PBF represents the feto-placental extraction of the substrate analog from the maternal PBF and fetal dpm/g placenta provides an estimate of placental transfer efficiency. Fetal and maternal blood concentrations of substrate analogs were measured in the d 44 and d 50 groups and placental/blood concentration ratios are given in Table 4 . Figures 1 and 2 show substrate uptake in growth-retarded fetuses expressed as percent of controls. The fetal uptake of AIB was unaffected in the ligated group at d 44 (Fig. I) , but was reduced by 33 (p < 0.05) and 18% (p < 0.05) at d 50 and 63, respectively. A tendency for increased extraction could be demonstrated, but was significantly higher only in late gestation. Placental efficiency to transfer AIB was reduced by 36% at d 50 63. Feto-placental dpm/PBF was increased at all stages of gestation studied, suggesting an increased extraction of MG from the maternal PBF. The wt-specific transfer capacity of the placenta was unchanged throughout gestation (Fig. 2) , and no difference in placental dpm/g placenta could be demonstrated (data not shown).
DISCUSSION
Our study is, to our knowledge, the first to describe substrate transfer characteristics of the growth-retarded hemochorial placenta in the awake, unstressed animal. Another novel aspect of these experiments is that they present placental transfer data from three stages of gestation, thereby demonstrating that pla- reduced during a prolonged period of late gestation. This find& adds evidence to the hypothesis that a reduced fetal amino acid availability due to an impaired placental transfer is a contributing factor to the development of growth retardation. We have also demonstrated that placental MG transfer to the growth-retarded fetuses in relation to FW is largely unaffected during the last 3 wk of gestation.
In our study, growth retardation was associated with an increased FW/PBF ratio, a characteristic also described for IUGR in humans (9) . As a consequence, the growth-retarded fetus is supplied by a lower maternal PBF per unit fetus, and to maintain substrate supply, the feto-placental unit must extract more from the placental circulation. In our study, the increased feto-placental dpm/PBF ratio for MG and, to some extent, for AIB indicate that this is the case. At d 44, only a moderate reduction of fetal and placental wt could be demonstrated despite a substantial increase in FW/PBF. Inasmuch as guinea pig fetuses weigh approximately 4 g at the time of ligation (lo), this suggests that fetal growth is relatively independent of PBF until d 44 of gestation. This finding is consistent with an earlier report from this laboratory (1 1) in which no correlation could be demonstrated between FW and PBF at d 45 of gestation after unilateral uterine artery ligation 2 wk earlier.
The placental transfer of AIB (fetal dpm/g fetus) was substantially reduced in growth retardation both at d 50 and 63 of gestation (Fig. I) . Our data are in line with the results of Nitzan et al. (7) , who studied placental AIB transfer in the anesthetized rat after uterine artery ligation and were able to demonstrate a large reduction in AIB-uptake in IUGR fetuses. In addition, Saintonge and Rosso (8) have shown in the anesthetized guinea pig that fetuses of a lower wt than average due to natural intralitter variations also have a slightly reduced uptake of AIB per g fetus. AIB is transferred by the sodium-dependent amino acid transporting system that is responsible for the transport of glycine, alanine, and serine. In the study of Cetin et al. (5) , in which the amino acid profiles in human umbilical blood were described, serine was one of the six amino acids that had a lower umbilical vein concentration in growth-retarded compared with appropriately grown fetuses.
Reductions in PBF result in a reduced transfer of a-amino nitrogen to the fetus (12, 13). Other factors that are likely to influence the rate of placental amino acid transfer are the placental membrane area available for exchange and the transfer efficiency of the placental barrier. In human idiopathic IUGR, microvillous surface area in relation to FW has been shown to be substantially increased (14) . Provided that amino acid transfer mainly occurs in the microvillous part of the placental barrier, this will tend to enhance amino acid transfer in IUGR. However, studies of AIB transport in human placental microvilli vesicles have demonstrated that cell membranes from placentas of smallfor-gestational-age infants have a decreased transfer capacity (1 5 
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The placental/maternal blood concentration ratios for MG .g 2 9 a , ratios well below 1; despite that, they exhibited a 5-6% reduction ' -a E E in wt-specific MG uptake, which is identical to that of the group $ 8 were clearly independent of placental/maternal blood concentra-Y 0 , + * tion ratios, we conclude that the fact that the mean ratios were close to 1 will not influence the comparison between growthretarded and normal-sized fetuses. The wt-specific fetal uptake of MG was slightly but significantly reduced in the growth-retarded group at d 50 of gestation. This is in agreement with a study carried out in the anesthetized rat (7) in which placental transfer of MG was reduced by 17% in a group of growth-retarded fetuses at d 20 of gestation after uterine artery ligation at d 18. In our study, no reduction in placental transfer of MG could be demonstrated at d 63 of gestation due to a maintained placental efficiency to transport MG (expressed as fetal dpm/g placenta) together with an increased uteroplacental extraction to compensate for the increase in FW/PBF. Transport studies with light scattering techniques on guinea pig placentas at d 63 of gestation show that microvillous membranes from growth-retarded placentas transport glucose as efficiently as membranes from normal-sized placentas (Illsley N, Jansson T, unpublished data), which is compatible with our observations. In addition, an increased materno-fetal concentration gradient, due to fetal hypoglycemia in IUGR (2), will stimulate the transplacental glucose transfer. Thus, an unchanged specific efficiency of the placental membrane to transfer glucose, a steeper concentration gradient, and possibly an increased microvillous-surface area in guinea pig IUGR seem to counteract the effect of reduced PBF on glucose transfer.
In the fetal sheep, experimental growth retardation seems to be associated with an increased placental efficiency to transport glucose (6) . Furthermore, a redistribution of glucose consumption from the placenta to the fetus is observed when placental growth is restricted (I). Our results do not support a reduced glucose uptake in the growth-retarded placenta of the guinea pig, inasmuch as no difference in placental dpm/g placenta could be demonstrated between groups. These discrepancies between the two animal models may be due to fundamental differences in the way of inducing growth retardation. In the sheep, uterine caruncles are excised before conception, restricting the number of cotyledons that develop during early placental growth. Consequently, the restriction is present during the entire pregnancy, unlike with uterine artery ligation in rodents, where pregnancy continues undisturbed until midgestation, when PBF is reduced. In the sheep model, the fetallplacental wt ratio increases (I), whereas in the guinea pig model, as in the human (9), fetal and placental wt are reduced in proportion. Moreover, the sheep placental type is epiteliochorial and may have other transport characteristics than the hemochorial placentas of guinea pigs and humans.
The unaffected placental transfer of MG in late gestation in our study indicates that the fetal hypoglycemia associated with IUGR in the guinea pig (2) is caused, at least in part, by factors other than reduced transplacental supply of glucose. The reduced fetal AIB uptake demonstrated in our study may restrict the availability of gluconeogenetic substrates and contribute to reduced plasma levels of glucose. In addition, both animal experimental (1 9) and human data (21) suggest that gluconeogenesis is impaired in fetal growth retardation, partly due to a delayed appearance of gluconeogenetic enzymes in the liver. An increased fetal consumption of glucose could also explain lower plasma glucose levels despite a maintained placental glucose transfer. However, no experimental support for this hypothesis is at hand, inasmuch as the growth-retarded fetal sheep has an unchanged glucose consumption (1).
Our results relating to glucose transfer in growth retardation in the guinea pig should not freely be extrapolated to the human. In a recent study by Economides and Nicolaides (3), umbilical artery and vein glucose concentrations were measured in smallfor-gestational-age fetuses by means of cordocentesis. They demonstrated a slightly reduced umbilical vein-artery concentration difference of glucose in growth-retarded compared with normalsized fetuses. If this information is combined with data of umbilical volume blood flow obtained from Doppler studies of growth-retarded fetuses (22) , suggesting a reduced umbilical flow/kg fetus, a reduced fetal uptake of glucose per kg fetus in human IUGR seems possible.
In conclusion, our results demonstrate that experimental growth retardation in the guinea pig is associated with a substantial reduction of FW-specific placental transfer of AIB, indicating that the growth-retarded fetus has an impaired supply of amino acids during intrauterine life. This reduction is suggested to be partly due to alterations at the placental barrier level and will contribute to the development of growth retardation independent of the PBF decrease per se. Placental transfer of MG per g fetus was o g y moderately reduced at d 50 of gestation, but otherwise maintained. Fetal hypoglycemia in guinea pig IUGR is therefore likely to be due, at least in part, to factors other than impaired placental glucose transfer.
